Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Recurrence 2Penile Neoplasms 2Neoplasms 2Hodgkin Disease 2Carcinoma, Squamous Cell 2Anus Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Pheochromocytoma 1Paraganglioma 1Papillomavirus Infections 1Neuroendocrine Tumors 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 8fludarabine 7pembrolizumab 6aldesleukin 4Interleukin-2 3spartalizumab 2fludarabine phosphate 2entinostat 2Vorinostat 2Trastuzumab 2Nivolumab 2Erlotinib Hydrochloride 2Biopsy 2Adoptive Transfer 2trastuzumab deruxtecan 1tislelizumab 1tipifarnib 1prexasertib 1oncogene protein E7, Human papillomavirus type 16 1nanocis 1enzalutamide 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1abiraterone 1Tomography, X-Ray Computed 1Thalidomide 1Technetium-99 1Taxes 1SRA737 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anus Neoplasms × fludarabine phosphate × Head & Neck × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡